ampelopsin has been researched along with eudragit rs in 1 studies
Studies (ampelopsin) | Trials (ampelopsin) | Recent Studies (post-2010) (ampelopsin) | Studies (eudragit rs) | Trials (eudragit rs) | Recent Studies (post-2010) (eudragit rs) |
---|---|---|---|---|---|
377 | 2 | 343 | 376 | 5 | 148 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bochi, GV; Dalcin, AJF; Gomes, P; Guarda, NS; Moresco, RN; Nascimento, K; Ourique, AF; Sagrillo, MR; Schuch, AP; Vizzotto, BS | 1 |
1 other study(ies) available for ampelopsin and eudragit rs
Article | Year |
---|---|
Nanoencapsulation of the flavonoid dihydromyricetin protects against the genotoxicity and cytotoxicity induced by cationic nanocapsules.
Topics: Acrylic Resins; Antioxidants; Cations; Cell Line, Tumor; Cell Survival; Comet Assay; DNA Damage; Flavonoids; Flavonols; Humans; Leukocytes, Mononuclear; MCF-7 Cells; Nanocapsules; Nanotechnology; Particle Size; Polymers; Proteins | 2019 |